A prospective multicenter study assessing humoral immunogenicity and safety of the mRNA SARS-CoV-2 vaccines in Greek patients with systemic autoimmune and autoinflammatory rheumatic diseases

OBJECTIVES: To investigate humoral responses and safety of mRNA SARS-CoV-2 vaccines in systemic autoimmune and autoinflammatory rheumatic disease (SAARD) patients subjected or not to treatment modifications during vaccination. METHODS: A nationwide, multicenter study, including 605 SAARD patients an...

Descripción completa

Detalles Bibliográficos
Autores principales: Tzioufas, Athanasios G., Bakasis, Athanasios-Dimitrios, Goules, Andreas V., Bitzogli, Kleopatra, Cinoku, Ilir I., Chatzis, Loukas G., Argyropoulou, Ourania D., Venetsanopoulou, Aliki I., Mavrommati, Maria, Stergiou, Ioanna E., Pezoulas, Vasilis, Voulgari, Paraskevi V., Katsimpari, Chaido, Katechis, Spyridon, Gazi, Souzana, Katsifis, Gkikas, Sfontouris, Charalampos I., Georgountzos, Athanasios I., Liossis, Stamatis-Nick, Papagoras, Charalampos, Fotiadis, Dimitrios I., Skopouli, Fotini N., Vlachoyiannopoulos, Panayiotis G., Moutsopoulos, Haralampos M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552665/
https://www.ncbi.nlm.nih.gov/pubmed/34757289
http://dx.doi.org/10.1016/j.jaut.2021.102743

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552665/
https://www.ncbi.nlm.nih.gov/pubmed/34757289
http://dx.doi.org/10.1016/j.jaut.2021.102743

Ejemplares similares